|
Frequency of usual passive smoking exposure at home
|
CANPATH_0000559 |
|
|
Lifetime occurrence of psoriasis in children
|
CANPATH_0000317 |
|
|
Brand name of medication from the Drug Product Database (DPD) - medication 8
|
CANPATH_0000796 |
|
|
Currently uses other types of tobacco or nicotine products
|
CANPATH_0000554 |
|
|
Number of children with irritable bowel syndrome
|
CANPATH_0000312 |
|
|
Drug code from the Drug Product Database (DPD) - medication 8
|
CANPATH_0000795 |
|
|
Currently smokes sheesha
|
CANPATH_0000553 |
|
|
Lifetime occurrence of irritable bowel syndrome in children
|
CANPATH_0000311 |
|
|
Anatomical Therapeutic Chemical (ATC) code - medication 8
|
CANPATH_0000798 |
|
|
Duration of passive smoking exposure during childhood
|
CANPATH_0000556 |
|
|
Number of children with eczema
|
CANPATH_0000314 |
|
|
Anatomical Therapeutic Chemical (ATC) code (match) - medication 8
|
CANPATH_0000797 |
|
|
Other types of tobacco or nicotine products currently used, specify
|
CANPATH_0000555 |
|
|
Lifetime occurrence of eczema in children
|
CANPATH_0000313 |
|
|
Lifetime occurrence of multiple sclerosis in children
|
CANPATH_0000319 |
|
|
Frequency of usual passive smoking exposure at work
|
CANPATH_0000561 |
|
|
Frequency of usual passive smoking exposure during leisure activities
|
CANPATH_0000560 |
|
|
Frequency of vigorous activities
|
CANPATH_0000563 |
|
|
Lifetime occurrence of osteoporosis in children
|
CANPATH_0000321 |
|
|
IPAQ version
|
CANPATH_0000562 |
|
